Molecular Diagnostics, the IVD industry’ segment, refers to the tests measuring DNA and RNA, as well as various products of metabolism to discover mutations, specific genotypes or any biochemical alterations which may be linked to certain health states or disease conditions. This science owns its emergence to the advancements in biology that have deepened the knowledge of the mechanisms of molecular-level processes, both normal and malignant.
Molecular Diagnostics is by far the most hastily progressing sector. The oncoming decade will be ear-marked by far-reaching advances in reagent and automation systems, along with the advent of a generous assortment of novelties set to inevitably call for innovative marketing techniques. The percentage of market penetration into day-to-day habitual clinical lab settings, though, will revolve around the arrival of money’s worth and automatized systems with amplification techniques. Some of the firms reigning over the market are Abbott Diagnostics, Celera, Sysmex Corporation, Roche Diagnostics, Qiagen N.V., Siemens Medical Solutions Diagnostics, and more.
The research reports from this Catalogue look at the Molecular Diagnostics Market on every imaginable geography level, covering key technology and medical trends. The issues mentioned in the research reports are varied, ranging from market sizing, share and segmentation to new product introductions and regulatory landscape. Further, the research reports highlight market penetration strategies, potential enter barriers, competitive profiles, besides offering the Molecular Diagnostics Market forecasts.
Publications found:
1,148
Sort by:
In-Situ Hybridization (ISH) Market - 2022
US$ 2,999.00
The In-Situ Hybridization (ISH) Market was valued at US$ 9700.40 million in 2022 and is anticipated to reach by , at a CAGR of 0.119 from 2026 to 2032. The report delivers in-depth insights into key m...
November 2025
243 pages
In-vitro Cancer Diagnostics Market 2026
US$ 2,999.00
The In-vitro Cancer Diagnostics Market was valued at in and is anticipated to reach by , at a CAGR of 0.039 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including...
November 2025
223 pages
Isothermal Nucleic Acid Amplification Technology Market 2026
US$ 2,999.00
The Isothermal Nucleic Acid Amplification Technology Market was valued at in and is anticipated to reach by , at a CAGR of 0.111 from 2026 to 2032. The report delivers in-depth insights into key marke...
November 2025
219 pages
Lymph Cancer Testing Market - 2023-2031
US$ 2,999.00
The Lymph Cancer Testing Market was valued at US$ 8.5 billion in 2023 and is anticipated to reach US$ 19.63 billion by 2031, at a CAGR of 0.113 from 2026 to 2032. The report delivers in-depth insights...
November 2025
223 pages
Newborn Screening Market 2026
US$ 2,999.00
The Newborn Screening Market was valued at in and is anticipated to reach by , at a CAGR of 0.107 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...
November 2025
223 pages
Non-Laboratory-based Cannabis Testing Market 2026
US$ 2,999.00
The Non-Laboratory-based Cannabis Testing Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, i...
November 2025
243 pages
PCR Systems Market 2026
US$ 2,999.00
The PCR Systems Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growth t...
November 2025
223 pages
Prostate Cancer Diagnostics Market - 2022-2031
US$ 2,999.00
The Prostate Cancer Diagnostics Market was valued at US$ 5.1 billion in 2022 and is anticipated to reach US$ 11.6 billion by 2031, at a CAGR of 0.111 from 2026 to 2032. The report delivers in-depth in...
November 2025
223 pages
Sickle Cell Anaemia Testing Market 2026
US$ 2,999.00
The Sickle Cell Anaemia Testing Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including r...
November 2025
207 pages
Syndromic Multiplex Diagnostic Market 2026
US$ 2,999.00
The Syndromic Multiplex Diagnostic Market was valued at in and is anticipated to reach by , at a CAGR of 0.073 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includ...
November 2025
223 pages
Tissue Microarray Market 2026
US$ 2,999.00
The Tissue Microarray Market was valued at in and is anticipated to reach by , at a CAGR of 0.1 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional gr...
November 2025
220 pages
Liquid Biopsy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Offering (Testing Services, Kits, Platform, Other consumables), By Technology (Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), Others), By Workflow (Sample Preparation, Library Preparation, Sequencing, Data Analysis & Management), By Sample (Blood, Urine, Saliva, Others), By Circulating Biomarkers (Circulating Tumor Cells (CTCs), Cell-free Nucleic Acids, Exosomes & Extracellular Vesicles), By Application (Oncological and Non-oncological), By End User (Clinical Laboratories, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Liquid Biopsy Market, valued at USD 4.93 Billion in 2024, is projected to experience a CAGR of 12.50% to reach USD 9.99 Billion by 2030. The global liquid biopsy market focuses on diagnosti...
November 2025
185 pages
Minimal Residual Disease (MRD) Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology (Flow Cytometry, Polymerase Chain Reaction, Next Generation Sequencing, Others), By Application (Leukemia, Lymphoma, Multiple Myeloma, Others), By End User (Hospitals & Specialty Clinics, Academic & Research Institutions, Clinical Laboratories, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Minimal Residual Disease (MRD) Testing Market, valued at USD 1.45 Billion in 2024, is projected to experience a CAGR of 8.70% to reach USD 2.39 Billion by 2030. Minimal residual disease (MR...
November 2025
185 pages
EV-Based Liquid Biopsy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Offering (Kits & Assays, Services, Instruments), By Workflow (Sample Preparation, Sequencing, Data Analysis), By Technology (Isolation Technologies, Analysis Technologies), By Sample Type (Blood, Urine, Saliva, and Others), By End user (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Clinical Laboratories), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global EV-Based Liquid Biopsy Market , valued at USD 91.12 Million in 2024, is projected to experience a CAGR of 9.74% to reach USD 159.14 Million by 2030. Extracellular vesicle (EV)-based liquid...
November 2025
185 pages
Automated Nucleic Acid Extraction Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents & Consumables), By Technology (Magnetic Bead-based, Column-based), By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The global automated nucleic acid extraction market size was valued at USD 3.22 billion in 2024 and is expected to reach USD 8.77 billion by 2033, registering a CAGR of 11.89% from 2025 to 2033. Conti...
November 2025
120 pages
India Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents & Consumables), By Test Location, By Technology, By Platform, By Application, By End Use, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The India molecular diagnostics market size was estimated at USD 1,054.80 million in 2024 and is projected to reach USD 1,717.27 million by 2033, growing at a CAGR of 5.63% from 2025 to 2033. The grow...
November 2025
150 pages
Nucleic Acid Amplification Testing Market Size, Share & Trends Analysis By Type (Polymerase Chain Reaction Tests, Isothermal Nucleic Acid Amplification Technology Tests, Ligase Chain Reaction Tests), By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The global nucleic acid amplification test (NAAT) market is expected to reach USD 4.4 Billion by 2025, according to a new report by Grand View Research, Inc. Nucleic acid amplification testing is gaining preference over traditional ...
October 2025
150 pages
In Situ Hybridization Market Outlook 2025-2034: Market Share, and Growth Analysis By Product (Analytical Instruments, Kits and Reagents, Software and Services, Other Products), By Technique (Fluorescence In Situ Hybridization (FISH), Chromogenic In Situ hybridization (CISH)), By Probe, By Application, By End Use
US$ 3,950.00
The In Situ Hybridization Market is valued at USD 2.3 billion in 2025 and is projected to grow at a CAGR of 11% to reach USD 5.9 billion by 2034.The In Situ Hybridization (ISH) Market is a key segment...
October 2025
160 pages
Real-Time Pcr, Digital Pcr And End-Point Pcr Market Outlook 2025-2034: Market Share, and Growth Analysis By Product (Instruments, Consumables And Reagents, Software And Services), By Technology (Quantitative, End-Point Polymerase Chain Reaction (PCR), Digital), By Applications
US$ 3,950.00
The Real-Time Pcr, Digital Pcr And End-Point Pcr Market is valued at USD 35.2 billion in 2025 and is projected to grow at a CAGR of 9% to reach USD 76.6 billion by 2034. Market Overview The real-time...
October 2025
160 pages
Global Digital Pathology Market - 2024-2033
US$ 2,999.00
The Global Digital Pathology Market was valued at US$ 1.31 Billion in 2024 and is anticipated to reach US$ 3.86 Billion by 2033, at a CAGR of 0.129 from 2026 to 2032. The report delivers in-depth insi...
October 2025
217 pages
Microarray Market - 2024-2033
US$ 2,999.00
The Microarray Market was valued at US$ 5.65Billion in 2024 and is anticipated to reach US$ 9.48Billion by 2033, at a CAGR of 0.059 from 2026 to 2032. The report delivers in-depth insights into key ma...
October 2025
219 pages
Global Polymerase Chain Reaction (PCR) Market - 2023-2033
US$ 2,999.00
The Global Polymerase Chain Reaction (PCR) Market was valued at US$ 11.58 Billion in 2023 and is anticipated to reach US$ 22.66 Billion by 2033, at a CAGR of 0.07 from 2026 to 2032. The report deliver...
October 2025
200 pages
DNA Forensics Market - 2023-2033
US$ 2,999.00
The DNA Forensics Market was valued at US$ 2.90 billion in 2023 and is anticipated to reach US$ 5.60 billion by 2033, at a CAGR of 0.077 from 2026 to 2032. The report delivers in-depth insights into k...
September 2025
243 pages
Molecular Diagnostics Market by Product & Service (Kits, Instruments, Software), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (PCR, NGS, ISH), and Application (Infectious (Hepatitis, HIV, HAI, Flu), Cancer (Breast, Lung)) - Global Forecast to 2030
US$ 4,950.00
... Research coverage: In this report, the molecular diagnostics market is segmented on the basis of product & service, application, technology, end user, and region ... top players in the global molecular diagnostics market. The report analyzes the market, by product & service, application, technology, end user, and ...
September 2025
540 pages
Molecular Diagnostics: Technologies and Global Markets
US$ 4,650.00
The global molecular diagnostics market was valued at nearly $10.6 billion in 2016. The market is projected to grow at a compound annual growth rate (CAGR) of 14.3% ... , at a CAGR of 20.1% from 2017-2022. The market for polymerase chain reaction (PCR)-based diagnostic assays should reach $4.5 billion by 2017 and ...
September 2025
142 pages
Middle East Oncology Based Molecular Diagnostics Market Size, Share & Trends Analysis Report By Type (Breast Cancer, Lung Cancer, Prostate Cancer, Liver Cancer), By Product (Instruments, Reagents), By Technology, By Country, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
Market Size & Trends The Middle East oncology based molecular diagnostics market size was estimated at USD 82.5 million in 2024 and is projected to grow at a CAGR of 5.6% from 2025 to 2033. Growth in...
September 2025
320 pages
Global Liquid Biopsy Market - 2024-2033
US$ 2,999.00
The Global Liquid Biopsy Market was valued at US$ 9.07 billion in 2024 and is anticipated to reach US$ 25.19 billion by 2033, at a CAGR of 0.107 from 2026 to 2032. The report delivers in-depth insight...
September 2025
210 pages
Noninvasive Cancer Diagnostics Market - 2024-2033
US$ 2,999.00
The Noninvasive Cancer Diagnostics Market was valued at USD 109.61 Billion in 2024 and is anticipated to reach USD 255.25 Billion by 2033, at a CAGR of 0.099 from 2026 to 2032. The report delivers in-...
September 2025
219 pages
India Molecular Diagnostics Market By Application (Infectious Disease, Blood Screening, Genetic Testing, Oncology Testing), By Technology (PCR, In-situ Hybridization, Chips and Microarrays, Mass Spectrometry, Sequencing, Others), By End User (Hospitals, Academic & Reference Laboratories), By Region, Competition, Forecast & Opportunities, 2020-2030F
US$ 3,500.00
Market Overview India Molecular Diagnostics Market was valued at USD 941.24 Million in 2024 and is expected to reach USD 1413.74 Million by 2030, growing at a CAGR of 7.12% during the forecast period...
August 2025
85 pages
Molecular Diagnostics In Pharmacogenomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Kits and Assays, Reagents, Services, Others), By Therapeutic Area (Oncology, Neurological Disorders, Cardiovascular Disease, Immunological Disorders, Infectious Diseases, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
Market Overview Global Molecular Diagnostics In Pharmacogenomics Market was valued at USD 686.40 Million in 2024 and is expected to reach USD 969.32 Million by 2030 with a CAGR of 6.12%. The global m...
August 2025
185 pages
Companion Diagnostics Market - 2022
US$ 2,999.00
The Companion Diagnostics Market was valued at US$ 6.1 billion in 2022 and is anticipated to reach by , at a CAGR of 0.122 from 2026 to 2032. The report delivers in-depth insights into key market dyna...
August 2025
220 pages
Global PCR Technologies Market Size Study & Forecast, by Product (Services, Software, Instruments, and Reagents & Consumables), by Technology (Digital PCR, Traditional PCR, Real-Time PCR, Multiplex PCR, Hot-Start PCR, and Others), by Application (Forensic, Research, Clinical, and Non-Medical), by End-User (Hospitals & Diagnostic Labs, Applied Industries, Pharma-Biotech Companies, Academia & Government Organizations, and Healthcare Industry) and Regional Forecasts 2025-2035
US$ 3,218.00
The Global PCR Technologies Market was valued at approximately USD 16.95 billion in 2024 and is projected to expand at a compound annual growth rate (CAGR) of 8.00% over the forecast period from 2025...
August 2025
285 pages
Global Digital PCR Market Size Study & Forecast, by Type (Droplet Digital PCR, Chip-based Digital PCR, and Others), Product (Instruments and Reagents & Consumables), Indication (Infectious Diseases, Oncology, Genetic Disorders, and Others), End-user (Hospitals & Clinics, Pharmaceutical & Biotechnology Industries, Clinical Laboratories, and Academic & Research Organizations), and Regional Forecasts 2025-2035
US$ 3,218.00
The Global Digital PCR Market is valued at approximately USD 0.7 billion in 2024 and is anticipated to expand at a stellar CAGR of over 23.1% during the forecast period from 2025 to 2035. Digital PCR...
August 2025
285 pages
Global APAC In Situ Hybridization Market Size Study & Forecast, by Products (Consumables, Instruments, Software), Technology (DNA FISH, RNA FISH, PNA FISH, CISH), Application (Cancer, Immunology, Neuroscience, Cytology), End-user (Hospital, Pharma, Biotech, CROs), and Regional Forecasts 2025–2035
US$ 3,218.00
Amid the rapidly evolving biomedical diagnostics landscape, the Asia-Pacific (APAC) region has emerged as a fertile ground for transformative molecular techniques such as In Situ Hybridization (ISH)....
August 2025
285 pages
Global Oncology Companion Diagnostics Market - 2024-2033
US$ 2,999.00
The Global Oncology Companion Diagnostics Market was valued at US$ 5.02 Billion in 2024 and is anticipated to reach US$ 10.90 Billion by 2033, at a CAGR of 0.091 from 2026 to 2032. The report delivers...
August 2025
200 pages
Real Time PCR Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Reagents & Consumables, Instruments, Software & Services), By Application (Clinical Diagnostics, Research, Forensic), By End-User (Hospitals and Diagnostic Centers, Pharmaceutical, CROs and Biotechnology Companies, Research Laboratories and Academic Institutes, Forensic Laboratories), By Region and Competition, 2020-2030F
US$ 4,500.00
Market Overview Global Real Time PCR Market was valued at USD 4.33 Billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 4.56% through 2030F. Real-time...
August 2025
185 pages
Molecular Diagnostics Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Products and Services (Reagents and Kits, Instruments, Services & Software), By Technology (Polymerase Chain Reaction (PCR), Sequencing, In-situ hybridization, Chips and microarrays, Mass spectrometry, Others), By Application (Infectious disease, Oncology testing, Genetic testing, Blood screening, Others), By End User (Hospitals, Academic & Reference Laboratories, Others), By Region & Competition, 2020-2030F
US$ 4,500.00
Market Overview Global Molecular Diagnostics market was valued at USD 17.65 Billion in 2024 and is expected to reach USD 26.70 Billion by 2030 with a CAGR of 7.10%. Molecular diagnostics, as a term,...
August 2025
165 pages
Molecular Diagnostics In Pharmacogenomics Market Size, Share & Trends Analysis Report By Product (Kits & Assays, Reagents, Services), By Therapeutic Area, By Technology, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
Molecular Diagnostics In Pharmacogenomics Market The global molecular diagnostics in pharmacogenomics market size was estimated at USD 699.7 million in 2024 and is projected to reach USD 1, 256.38 mil...
August 2025
150 pages
Liquid Biopsy Market by Product & Service (Kits, Instruments), Circulating Biomarker (ctDNA, cfDNA, CTC), Technology (NGS, PCR), Application (Lung, Breast, Prostate Cancer), Sample Type (Blood, Urine, CSF), End User (Hospitals) - Global Forecast to 2030
US$ 4,950.00
... during the forecast period” Based on application, the liquid biopsy market is segmented into cancer and non-cancer applications (which include reproductive health and organ ...
August 2025
393 pages
Companion Diagnostics Market Report by Product & Service (Assays, Kits and Reagents, Software and Services), Technology (Immunohistochemistry (IHC), Polymerase Chain Reaction (PCR), In-situ Hybridization (ISH), Real-time PCR (RT-PCR), Gene Sequencing, and Others), Indication (Cancer, Neurological Diseases, Infectious Diseases, Cardiovascular Diseases, and Others), End User (Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations, and Others), and Region 2025-2033
US$ 2,999.00
The global companion diagnostics market size reached USD 7.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 22.3 Billion by 2033, exhibiting a growth rate (CAGR) of 12.1...
August 2025
149 pages
